Skip to main content
Clinical Trials/ACTRN12615000791538
ACTRN12615000791538Completed未知

An evaluation of the efficacy of curcumin and saffron for the treatment of depression: a randomised, double-blind, placebo controlled-trial

Murdoch University0 sites160 target enrollmentStarted: July 30, 2015Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
160

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • 1. Male or female aged between 18 and 65 years
  • 2. Suffering from depression (mild to moderate severity) as assesed by the Mini International Neuropsychiatric interview
  • 3. Medication-free for at least 3 months (except pharmaceutical antidepressants and contraceptive pill)
  • 4. Non-smoker

Exclusion Criteria

  • 1. Suffer from a diagnosable mental health disorder other than depression e.g., eating disorder, psychosis/ schizophrenia.
  • 2. Suffer from medical illnesses including diabetes, autoimmune diseases, cardiovascular disease, hypertension, chronic fatigue syndrome, asthma.
  • 3. Pregnant or intend to fall pregnant
  • 4. Currently breastfeeding
  • 5. Have suffered from an infection or illness over the last month (includes the common cold)
  • 6. Currently take any antiplatelet (e.g., Aspirin, non-steroidal anti-inflammatories, clopidogrel, dipyridamole, abciximab, tirofiban) and anticoagulant medications (e.g., Warfarin, rivaroxaban, dabigatran etexilate)

Investigators

Similar Trials